HS-301

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameHS-301
Drug Alias NameHS-301HS301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene tyrosine-protein kinase ROS inhibitorsTropomyosin-related kinase inhibitors
TargetsProto-oncogene tyrosine-protein kinase ROSTropomyosin-related kinase
Therapy Area/IndicationsSolid tumoursNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesHanhui Pharmaceuticals Company Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesHanhui Pharmaceuticals Company Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A